IT8468241A0 - Derivati del triptofano farmaceuti camente attivi e composizioni farmaceutiche che li contengono - Google Patents

Derivati del triptofano farmaceuti camente attivi e composizioni farmaceutiche che li contengono

Info

Publication number
IT8468241A0
IT8468241A0 IT8468241A IT6824184A IT8468241A0 IT 8468241 A0 IT8468241 A0 IT 8468241A0 IT 8468241 A IT8468241 A IT 8468241A IT 6824184 A IT6824184 A IT 6824184A IT 8468241 A0 IT8468241 A0 IT 8468241A0
Authority
IT
Italy
Prior art keywords
compositions containing
pharmaceutical
tryptophan derivatives
pharmaceutical compositions
active
Prior art date
Application number
IT8468241A
Other languages
English (en)
Other versions
IT8468241A1 (it
IT1179866B (it
Inventor
Francesco Makovec
Rolando Chiste
Luigi Rovati
Original Assignee
Rotta Research Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rotta Research Lab filed Critical Rotta Research Lab
Publication of IT8468241A0 publication Critical patent/IT8468241A0/it
Priority to IT68241/84A priority Critical patent/IT1179866B/it
Priority to IE302985A priority patent/IE58502B1/en
Priority to JP61500191A priority patent/JPS62501292A/ja
Priority to AT86900106T priority patent/ATE85976T1/de
Priority to EP86900106A priority patent/EP0237522B1/en
Priority to AU52099/86A priority patent/AU589938B2/en
Priority to PCT/EP1985/000672 priority patent/WO1986003489A1/en
Priority to DE8686900106T priority patent/DE3587122T2/de
Priority to CA000497174A priority patent/CA1256441A/en
Priority to ES549822A priority patent/ES8706630A1/es
Priority to ZA859526A priority patent/ZA859526B/xx
Priority to PT81674A priority patent/PT81674B/pt
Publication of IT8468241A1 publication Critical patent/IT8468241A1/it
Priority to DK381486A priority patent/DK168564B1/da
Application granted granted Critical
Publication of IT1179866B publication Critical patent/IT1179866B/it
Priority to US07/217,116 priority patent/US4870097A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT68241/84A 1984-12-12 1984-12-12 Derivati del triptofano farmaceuticamente attivi e composizioni farmaceutiche che li contengono IT1179866B (it)

Priority Applications (14)

Application Number Priority Date Filing Date Title
IT68241/84A IT1179866B (it) 1984-12-12 1984-12-12 Derivati del triptofano farmaceuticamente attivi e composizioni farmaceutiche che li contengono
IE302985A IE58502B1 (en) 1984-12-12 1985-12-02 Pharmaceutically active derivatives of tryptophan and pharmaceutical compostitions containing them
PCT/EP1985/000672 WO1986003489A1 (en) 1984-12-12 1985-12-05 Pharmaceutically active derivatives of tryptophan and pharmaceutical compositions containing them
AT86900106T ATE85976T1 (de) 1984-12-12 1985-12-05 Pharmakologisch aktive derivate von tryptophan und diese enthaltende pharmazeutische zusammensetzungen.
EP86900106A EP0237522B1 (en) 1984-12-12 1985-12-05 Pharmaceutically active derivatives of tryptophan and pharmaceutical compositions containing them
AU52099/86A AU589938B2 (en) 1984-12-12 1985-12-05 Tryptophan derivatives
JP61500191A JPS62501292A (ja) 1984-12-12 1985-12-05 トリプトファンの医薬的活性誘導体および該誘導体を含有する医薬組成物
DE8686900106T DE3587122T2 (de) 1984-12-12 1985-12-05 Pharmakologisch aktive derivate von tryptophan und diese enthaltende pharmazeutische zusammensetzungen.
CA000497174A CA1256441A (en) 1984-12-12 1985-12-09 Pharmaceutically active derivatives of tryptophan and pharmaceutical compositions containing them
ES549822A ES8706630A1 (es) 1984-12-12 1985-12-11 Procedimiento para la preparacion de derivados n-acilados del-triptofano
ZA859526A ZA859526B (en) 1984-12-12 1985-12-12 Pharmaceutically active derivatives of tryptophan and pharmaceutical compositions containing them
PT81674A PT81674B (pt) 1984-12-12 1985-12-12 Processo para a preparacao de derivados n-acilados de l-triptofano farmaceuticamente activos, das composicoes farmaceuticas e de um produto farmaceutico que os contem, aplicaveis para aliviar a dor em seres humanos
DK381486A DK168564B1 (da) 1984-12-12 1986-08-11 Anvendelse af N-acylerede derivater af L-tryptophan til fremstilling af et lægemiddel til lindring af human smerte, farmaceutiske præparater indeholdende dem, samt sådanne nye farmaceutisk aktive derivater
US07/217,116 US4870097A (en) 1984-12-12 1988-07-11 Pharmaceutical use of derivatives of tryptophan

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT68241/84A IT1179866B (it) 1984-12-12 1984-12-12 Derivati del triptofano farmaceuticamente attivi e composizioni farmaceutiche che li contengono

Publications (3)

Publication Number Publication Date
IT8468241A0 true IT8468241A0 (it) 1984-12-12
IT8468241A1 IT8468241A1 (it) 1986-06-12
IT1179866B IT1179866B (it) 1987-09-16

Family

ID=11308641

Family Applications (1)

Application Number Title Priority Date Filing Date
IT68241/84A IT1179866B (it) 1984-12-12 1984-12-12 Derivati del triptofano farmaceuticamente attivi e composizioni farmaceutiche che li contengono

Country Status (14)

Country Link
US (1) US4870097A (it)
EP (1) EP0237522B1 (it)
JP (1) JPS62501292A (it)
AT (1) ATE85976T1 (it)
AU (1) AU589938B2 (it)
CA (1) CA1256441A (it)
DE (1) DE3587122T2 (it)
DK (1) DK168564B1 (it)
ES (1) ES8706630A1 (it)
IE (1) IE58502B1 (it)
IT (1) IT1179866B (it)
PT (1) PT81674B (it)
WO (1) WO1986003489A1 (it)
ZA (1) ZA859526B (it)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4814463A (en) * 1985-12-31 1989-03-21 Biomeasure, Inc. CCK antagonists
US4880938A (en) * 1986-06-16 1989-11-14 Merck & Co., Inc. Amino acid analogs
US5089638A (en) * 1986-06-16 1992-02-18 Merck & Co., Inc. Amino acid analogs as CCK-antagonists
SE8901149D0 (sv) * 1989-04-03 1989-04-03 Pharmacia Ab Medel foer inducering respektive foerhindrande av pupillkonstriktion i oegat
US5360814A (en) * 1991-02-28 1994-11-01 Merrell Dow Pharmaceuticals Inc. NMDA antagonists
US5484814A (en) * 1991-02-28 1996-01-16 Merrell Dow Pharmaceuticals Inc. NMDA antagonists
DE69201141T2 (de) * 1991-02-28 1995-05-11 Merrell Dow Pharma NMDA-Antagonisten.
US20030199523A1 (en) * 2002-02-28 2003-10-23 Snutch Terrance P. Heterocyclic calcium in channel blockers
AU2003275075A1 (en) 2002-09-20 2004-04-08 The Trustees Of The University Of Pennsylvania Compstatin analogs with improved activity
BRPI0617186A2 (pt) 2005-10-08 2011-07-19 Potentia Pharmaceuticals Inc uso de análogo de compstatina, implante ocular, micropartìcula ou nanopartìcula, composição, composto multivalente, ácido nucléico, vetor de expressão, célula hospedeira recombinante, proteìna de fusão e método de produção e teste
US8168584B2 (en) 2005-10-08 2012-05-01 Potentia Pharmaceuticals, Inc. Methods of treating age-related macular degeneration by compstatin and analogs thereof
EP2377878B1 (en) * 2005-11-28 2018-03-28 The Trustees Of The University Of Pennsylvania Potent compstatin analogs
WO2008097525A2 (en) 2007-02-05 2008-08-14 Potentia Pharmaceuticals, Inc. Local complement inhibition for treatment of complement-mediated disorders
PT2424557T (pt) 2009-05-01 2018-02-05 Univ Pennsylvania Compstatina modificada com estrutura peptídica e modificações no terminal c
CA2813049A1 (en) 2010-09-23 2012-03-29 The Trustees Of The University Of Pennsylvania Modified compstatin with improved stability and binding properties
CA2826019C (en) 2011-01-26 2017-08-01 Nico Worldwide Inc. Remedy for migraine headache
BR112013028816B1 (pt) 2011-05-11 2020-12-15 Apellis Pharmaceuticals, Inc Análogos de compstatina, composição que os compreende e uso dos mesmos
JP6618682B2 (ja) 2011-06-22 2019-12-11 アペリス・ファーマシューティカルズ・インコーポレイテッドＡｐｅｌｌｉｓ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ． 補体阻害剤による慢性障害の治療方法
WO2013036778A2 (en) 2011-09-07 2013-03-14 The Trustees Of The University Of Pennsylvania Compstatin analogs with improved pharmacokinetic properties
DK2920201T3 (da) 2012-11-15 2020-04-14 Apellis Pharmaceuticals Inc Langtidsvirkende compstatin-analoger og relaterede sammensætninger og fremgangsmåder
WO2014152391A1 (en) 2013-03-15 2014-09-25 Apellis Pharmaceuticals, Inc. Cell-penetrating compstatin analogs and uses thereof
US10213476B2 (en) 2014-03-17 2019-02-26 The Trustees Of The University Of Pennsylvania Compstatin analogs with improved potency and pharmacokinetic properties
EP3359555B1 (en) 2015-10-07 2023-12-20 Apellis Pharmaceuticals, Inc. Dosing regimens
US10925857B2 (en) 2015-11-12 2021-02-23 The Trustees Of Columbia University In The City Of New York Rational drug design targeting resistant gram-negative bacterial infections to polymyxin-class antibiotics
BR112019020955A2 (pt) 2017-04-07 2020-05-05 Apellis Pharmaceuticals Inc regimes de dosagem e composições e métodos relacionados
WO2018200381A1 (en) 2017-04-25 2018-11-01 Temple Otorongo Llc Pharmaceutical composition comprising tryptophan and phyllokinin derivative for use in treating psychiatric and psychological conditions
CA3096078A1 (en) 2018-04-06 2019-10-10 The Trustees Of The University Of Pennsylvania Compstatin analogs with increased solubility and improved pharmacokinetic properties

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1055518B (it) * 1971-05-18 1982-01-11 Rotta Research Lab Derivatives del triptofano
US4482567A (en) * 1982-10-07 1984-11-13 Research Foundation For Mental Hygiene, Inc. N-hexanoyl to n-heptadecanoyl 5-hydroxy tryptophan-5-hydroxytryptophanamides and use as analgesics

Also Published As

Publication number Publication date
IE58502B1 (en) 1993-10-06
ES8706630A1 (es) 1987-06-01
DE3587122T2 (de) 1993-07-15
ES549822A0 (es) 1987-06-01
ATE85976T1 (de) 1993-03-15
PT81674B (pt) 1987-10-20
JPS62501292A (ja) 1987-05-21
EP0237522B1 (en) 1993-02-24
PT81674A (en) 1986-01-01
EP0237522A1 (en) 1987-09-23
DK168564B1 (da) 1994-04-25
AU589938B2 (en) 1989-10-26
DK381486A (da) 1986-08-11
IT8468241A1 (it) 1986-06-12
AU5209986A (en) 1986-07-01
US4870097A (en) 1989-09-26
WO1986003489A1 (en) 1986-06-19
IE853029L (en) 1986-06-12
ZA859526B (en) 1986-08-27
DK381486D0 (da) 1986-08-11
CA1256441A (en) 1989-06-27
DE3587122D1 (de) 1993-04-01
IT1179866B (it) 1987-09-16

Similar Documents

Publication Publication Date Title
IT8468241A0 (it) Derivati del triptofano farmaceuti camente attivi e composizioni farmaceutiche che li contengono
IT8648157A0 (it) Derivati del tiazolo, loro preparazione e composizioni farmaceutiche che li contengono
IT8647505A0 (it) Derivati della piperidina e della pirrolidina, loro preparazione e composizioni farmaceutiche che licontengono
IT8848714A0 (it) Derivati di adenosina, composizioni farmaceutiche che li contengono erelativo procedimento di preparazione ed appplicazione
IT1164699B (it) Derivati imidazolici composizioni farmaceutiche che li contengono e procedimento di applicazione
IT1215165B (it) Derivati del naftalene aventi azione retinoide procedimento per la loro preparazione e composizioni medicinali o cosmetiche che li con tengono
KR870700608A (ko) 아미노-살리실산 유도체 및 제약 조성물
IT8567757A0 (it) Derivati di benzonorbornene procedimento per la loro preparazione e composizioni medicinali e cosmetiche che li contengono
IT1203791B (it) Derivati del morfinano e della morfina,loro preparazione,loro impiego come medicamenti e e le composizioni farmaceutiche che li contengono
IT1181741B (it) Derivati di indolo,procedimento per prepararli e composizioni farmaceutiche che li contengono
IT1182061B (it) Derivati di amminofenolo, procedimento per prepararli e composizione farmaceutica che li contiene
IT1182089B (it) Derivati di indolo, procedimento, per prepararli e composizioni farmaceutiche che li contengono
IT1167123B (it) Benzoazacicloalchilspiro-imidazolidine,procedimento per prepararle e composizioni farmaceutiche che le contengono
IT1237470B (it) Derivati di imidazolo, procedimenti per produrli e composizioni farmaceutiche che li contengono
IT1205665B (it) Derivati 1-(idrossistiril)-5h2,3-benzodiazepinici,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
IT1195324B (it) Derivati encefalinici dotati di attivita' analgesica e composizioni farmaceutiche che li contengono
IT1209846B (it) Derivati eterociclici antistaminici procedimento per prepararli e composizioni farmaceutiche che li contengono
IT1208660B (it) Derivati di 2,5-diammino-1,4-diazolo,procedimento per prepararli e composizioni farmaceutiche che licontengono
IT1205360B (it) Derivati di dioloroanilina,procedimento per prepararli e composizioni farmaceutiche che li contengono
IT1193590B (it) Derivati amino-alchil-solfonici,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
IT8667976A0 (it) Derivati teofillinmetilditiolanici e teofillinmetilditianici procedimento per la loro preparazione e composizioni farmaceutiche che li comprendono
IT1201497B (it) Derivati tienopiridinici,procedimento per la loro preparazione e composizioni terapeutiche che li contengono
IT1168389B (it) Derivati di alcandioli con attivita' ipolipidemizzante,metodi per la loro preparazione e composizioni farmaceutiche che li contengono
IT1181736B (it) Derivati di imidazopiridazina,composizione farmaceutica che li contiene e procedimento per prepararli
IT1211683B (it) Derivati di isochinolina, composizioni che li contengono e procedimento per prepararli ed applicarli

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19941230